Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Lisa M. Coussens(Oregon Health & Science University), Lynn M. Matrisian(Pancreatic Cancer Action Network), Barbara Fingleton(Vanderbilt University)
Cited by 2,748
Related Papers
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
|Cancer Research|2014|7.2k
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
|Cancer Cell|2012|4.7k
Metalloproteinases and their inhibitors in matrix remodeling
|Trends in Genetics|1990|1.6k
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
|Journal of Clinical Oncology|2000|1.6k
The matrix‐degrading metalloproteinases
|BioEssays|1992|1.4k